Daiichi Sankyo Espha Eyes 50 Billion Yen Sales in 2020 with AGs as Growth Engine

February 28, 2017
Daiichi Sankyo Espha President Hiroto Yoshiwaka Earning the green light for a hefty seven authorized generics (AGs) earlier this month, Daiichi Sankyo Espha is set to carve out a unique position in the industry, which it hopes will catapult it...read more